Design, synthesis and biological studies of tetrazole fused imidazopyridines

Reddy Banoth; Taneja Amit Kumar; Tej Mandava Bhuvan; Navya Sri Komati; Tej Mandava Bhagya; Vijayavardhini Suryadevara; Srilaxmi Dandamudi; Tiruveedhula Somasekhar; Penumutchu Srinivasa Rao; Rao Mandava V. Basaveswara

doi:10.1007/s42823-023-00603-2

Design, synthesis and biological studies of tetrazole fused imidazopyridines

Carbon Letters
Abbr : Carbon Lett.
2024, 34(1), pp.41~49
DOI : 10.1007/s42823-023-00603-2
Publisher : Korean Carbon Society
Research Area : Natural Science > Natural Science General > Other Natural Sciences General
Received : June 27, 2023
Accepted : August 29, 2023
Published : February 1, 2024

Reddy Banoth ¹, Taneja Amit Kumar ², Tej Mandava Bhuvan ³, Navya Sri Komati ³, Tej Mandava Bhagya ³, Vijayavardhini Suryadevara ⁴, Srilaxmi Dandamudi ⁵, Tiruveedhula Somasekhar ⁶, Penumutchu Srinivasa Rao ⁶, Rao Mandava V. Basaveswara ¹

¹인도 안드라프라데시주 마치리파트남 크리슈나 대학교
²Chaudhary Charan Singh University
³인도 안드라프라데시주 군투르 치나카카니 NRI 의학 아카데미 MBBS학과
⁴Amrita Sai Institute of Science and Technology
⁵Dhanekula Institute of Engineering and Technology
⁶인도, 500100, Telangana, Hyderabad, Dhulapally, St. Martin's Engineering College, 과학 및 인문학과

Accredited

ABSTRACT

New tetrazole fused imidazopyridine derivatives (12a–j) were developed to exploit their cytotoxic activity towards cancer cell lines-MCF7, A549, and MDA-MB-231, utilizing MTT reduction assay with doxorubicin as standard drug. The compounds 12 h and 12j demonstrated strong anticancer activity bearing IC50 values 1.44 µM and 1.33 µM against A549 cell line.

KEYWORDS

Zolpidem Alpidem Cephalosporin Anticancer activity

Citation status

This is the result of checking the information with the same ISSN, publication year, volume, and start page between the WoS and the KCI journals. (as of 2026-07-09)

Total Citation Counts(KCI+WOS) (1) This is the number of times that the duplicate count has been removed by comparing the citation list of WoS and KCI.

* References for papers published after 2025 are currently being built.

[journal] Musunuri S / 2021 / Synthesis of quinozilinium fluoroborate salts from harmine / Carbon Lett 31 : 297~305

[journal] Alugubelli GR / 2021 / Synthesis of γ-carboline derivatives via indole-2,3-dienolate / Carbon Lett 31 : 1155~1161

[journal] Vargheese S / 2020 / Triazine-based 2D covalent organic framework-derived nitrogen-doped porous carbon for supercapacitor electrode / Carbon Lett 31 : 879~886

[journal] Wu L / 2023 / Preparation and electrochemical performance of porous carbon derived from polypyrrole / Carbon Lett 33 : 443~454

[journal] Velázquez-Olvera S / 2012 / Fluorescent property of 3-hydroxymethyl imidazo[1, 2-a]pyridine and pyrimidine derivatives / Chem Cent J 6 : 83~

[journal] El Kazzouli S / 2011 / Design and synthesis of 2-phenylimidazo[1, 2-a]pyridines as a novel class of melatonin receptor ligands / Eur J Med Chem 46 : 4252~4257

[journal] Enguehard-Gueiffier C / 2007 / Recent progress in the pharmacology of imidazo [1, 2-a]pyridines / Minirev Med Chem 7 : 888~899

[journal] Dahan-Farkas N / 2011 / 6-Substituted imidazo[1, 2-a]pyridines : synthesis and biological activity against colon cancer cell lines HT-29 and Caco-2 / Eur J Med Chem 46 : 4573~4583

[journal] Chezal JM / 2010 / Synthesis and antiviral activity of an imidazo[1, 2-a]pyrrolo[2, 3-c]pyridine series against the bovine viral diarrhea virus / Eur J Med Chem 45 : 2044~2947

[journal] Al-Tel TH / 2011 / Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1, 2-a]pyridine and imidazo[2, 1-b][1, 3]benzo thiazole motifs / Eur J Med Chem 46 : 1874~1881

[journal] Hamdouchi C / 1999 / Short synthesis and anti-rhinoviral activity of imidazo[1, 2-a]pyridines : the effect of acyl groups at 3-position / Bioorg Med Chem Lett 9 : 1391~1394

[journal] Fisher MH / 1972 / Imidazo[1, 2-a]pyridine anthelmintic and antifungal agents / J Med Chem 15 : 982~985

[journal] Moraski GC / 2012 / Generation and exploration of new classes of antitubercular agents : the optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1, 2-a]pyridines and isomeric 5, 6-fused scaffolds / Bioorg Med Chem 20 : 2214~2220

[journal] Kaminski JJ / 1987 / Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1, 2-a]pyridines and analogs / J Med Chem 30 : 2031~2046

[journal] Ismail MA / 2004 / Novel dicationic imidazo[1, 2-a]pyridines and 5, 6, 7, 8-Tetrahydro-imidazo[1, 2-a]pyridines as antiprotozoal agents / J Med Chem 47 : 3658~3664

[journal] Goodacre SC / 2006 / Imidazo[1, 2-a]pyrimidines as functionally selective and orally bioavailable GABAAα2/α3 binding site agonists for the treatment of anxiety disorders / J Med Chem 49 : 35~36

[journal] Starr JT / 2009 / 5-(2-Pyrimidinyl)-imidazo[1, 2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV / Bioorg Med Chem Lett 19 : 5302~5306

[journal] Emmitte KA / 2009 / Discovery and optimization of imidazo[1, 2-a]pyridine inhibitors of insulin-like growth factor-1 receptor(IGF-1R) / Bioorg Med Chem Lett 19 : 1004~1008

[journal] Warshakoon NC / 2006 / Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors / Bioorg Med Chem Lett 16 : 5616~5620

[journal] Roelofs AJ / 2006 / Selective inhibition of rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells / Int J Cancer 119 : 1254~1261

[journal] Hamdouchi C / 2005 / Structure-based design of a new class of highly selective aminoimidazo[1, 2-a]pyridine-based inhibitors of cyclin dependent kinases / Bioorg Med Chem Lett 15 : 1943~1947

[journal] Kercher T / 2007 / Diversification of the three-component coupling of 2-aminoheterocycles, aldehydes, and isonitriles : Efficient parallel synthesis of a diverse and drug like library of imidazo-and tetrahydroimidazo[1, 2-a]heterocycles / J Comb Chem 9 : 1177~1187

[journal] Katritzky AR / 2003 / Regiospecific synthesis of 3-substituted imidazo [1, 2-a]pyridines, imidazo[1, 2-a]pyrimidines, and imidazo[1, 2-c]pyrimidine / J Org Chem 68 : 4935~4937

[journal] Langer SZ / 1990 / Zolpidem and alpidem : two imidazo pyridines with selectivity for omega 1-and omega 3-receptor subtypes / Adv Biochem Psychopharmacol 46 : 61~72

[journal] Okubo T / 2004 / Design, synthesis and structure–affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands / Bioorg Med Chem 12 : 423~438

[journal] Jain AN / 2004 / Ligand based structural hypotheses for virtual screening / J Med Chem 47 : 947~961

[journal] Harrison TS / 2005 / Zolpidem : a review of its use in the management of insomnia / CNS Drugs 19 : 65~89

[journal] Wiegand MH / 2008 / Antidepressants for the treatment of Insomnia / Drugs 68 : 2411~2417

[journal] Veron JB / 2008 / Influence of 6-or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo [1, 2-a]pyridine against human cytomegalovirus(CMV)and varicella-zoster virus(VZV) : part II / Bioorg Med Chem 16 : 9536~9545

[journal] Zubarev VY / 2000 / Methods for the synthesis of mono-and polynuclear NH-tetrazoles / Chem Het Comp 36 : 759~774

[journal] Romagnoli R / 2012 / Synthesis and evaluation of 1, 5-disubstituted tetrazoles as rigid analogues of Combretastatin A-4 with potent antiproliferative and antitumor activity / J Med Chem 55 : 475~488

[journal] Luo Y-P / 2008 / Synthesis and herbicidal activities of tetrazolinone derivatives containing oxime ether / Chin J Org Chem 28(9) : 1561~1565

[journal] Diwakar SD / 2008 / Substituted 3-((Z)-2-(4-nitro phenyl)-2-(1H-tetrazol-5-yl)vinyl)-4H-chromen-4-ones as novel anti-MRSA agents : synthesis, SAR, and in-vitro assessment / Bioorg Med Chem Lett 18 : 4678~4681

[journal] Yeung KS / 2013 / Inhibitors of HIV-1 attachment. Part 9 : An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative / Bioorg Med Chem Lett 23 : 209~212

[journal] Bertinaria M / 2012 / Designing multitarget anti-inflammatory agents : chemical modulation of the Lumiracoxib structure toward dual thromboxane antagonists–COX-2 inhibitors / Chem Med Chem 7 : 1647~1660

[journal] Gundugola AS / 2010 / Synthesis and antiproliferative evaluation of 5-oxo and 5-thio derivatives of 1, 4-diaryl tetrazoles / Bioorg Med Chem Lett 20 : 3920~3924

[journal] Trecant C / 2011 / Synthesis and biological evaluation of analogues of M6G / Eur J Med Chem 46 : 4035~4041

[report] Andres-Gil JI / 2006 / Preparation of triazolone, tetrazolone and imidazolone derivatives for use as alpha 2C-adrenoreceptor antagonists

[other] Shaw-Reid CA / 2005 / Preparation of tetrazolyl derivatives as HIV reverse transcriptase inhibitors. U.S. 16671 2005115147

[other] Cirino G / 2004 / EP 50779 2004043443

[other] Janssens FE / 1997 / EP 46609716440

[journal] Shih TL / 1999 / L-770, 644 : a potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability / Bioorg Med Chem Lett 9 : 1251~1254

[journal] Lee PY / 2003 / Clinical features and in vitro antimicrobial susceptibilities of community-acquired Klebsiella pneumoniae meningitis in Taiwan / Antimicrobial Agents Chem other 51 : 957~962

[journal] Thorn CF / 2011 / Doxorubicin pathways : pharmacodynamics and adverse effects / Pharmacogenet Genom 21 : 440~446

[journal] Verma A / 2022 / Tetrazole : a privileged scaffold for the discovery of anticancer agents / Chem Biol Drug Des 100 : 419~442

[journal] Yu Y / 2020 / Design, synthesis, and biological evaluation of Imidazo[1, 2-a]pyridine derivatives as novel PI3K/mTOR dual inhibitors / J Med Chem 63 : 3028~3046

[journal] Gkeka P / 2015 / Exploring a non-ATP pocket for potential allosteric modulation of PI3Kα / J Phys Chem B 119 : 1002~1016

KJCKorea
Journal Central

Carbon Letters 2025 KCI Impact Factor : 0.73 KCI-WoS Impact Factor : 6.26

Design, synthesis and biological studies of tetrazole fused imidazopyridines

ABSTRACT

KEYWORDS

Citation status

This is the result of checking the information with the same ISSN, publication year, volume, and start page between the WoS and the KCI journals. (as of 2026-07-09)

Total Citation Counts(KCI+WOS) (1) This is the number of times that the duplicate count has been removed by comparing the citation list of WoS and KCI.

* References for papers published after 2025 are currently being built.

Carbon Letters 2025 KCI Impact Factor : 0.73 KCI-WoS Impact Factor : 6.26

Design, synthesis and biological studies of tetrazole fused imidazopyridines

ABSTRACT

KEYWORDS

Statistics

Tools

Issue List

Citation status

KCI Citation Counts (0)

WoS Citation Counts (1) This is the result of checking the information with the same ISSN, publication year, volume, and start page between the WoS and the KCI journals. (as of 2026-07-09)

Total Citation Counts(KCI+WOS) (1) This is the number of times that the duplicate count has been removed by comparing the citation list of WoS and KCI.

REFERENCES (47) * References for papers published after 2025 are currently being built.

Search PDF

Citation

This is the result of checking the information with the same ISSN, publication year, volume, and start page between the WoS and the KCI journals. (as of 2026-07-09)

* References for papers published after 2025 are currently being built.